HEB Key Stats
|Revenue (Quarterly YoY Growth)||Upgrade|
|EPS Diluted (TTM)||-0.089|
|EPS Diluted (Quarterly YoY Growth)||Upgrade|
|Net Income (TTM)||-16.19M|
|Gross Profit Margin (Quarterly)||-580.0%|
|Profit Margin (Quarterly)||-9338%|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM)||Upgrade|
SA Breaking News02/20 07:15
SA Breaking News02/11 03:38
|11/10/2014||Earnings||Q3 2014 Hemispherx Biopharma Inc Earnings Results|
|08/11/2014||Earnings||Q2 2014 Hemispherx Biopharma Inc Earnings Results|
|05/09/2014||Earnings||Q1 2014 Hemispherx Biopharma Inc Earnings Results|
|03/14/2014||Earnings||Hemispherx Biopharma, Inc. Q4 2013 Earning Result|
HEB Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Hemispherx Biopharma is down 34.99% over the last year vs S&P 500 Total Return up 14.44%, Biocryst Pharmaceuticals down 20.26%, and Sarepta Therapeutics down 53.52%.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for HEB
Portfolio Strategies Featuring HEB
Did Hemispherx Biopharma make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Company Website: http://www.hemispherx.net
- IR Website: http://www.hemispherx.net/content/investor/
- HQ Country: United States
- HQ State/Province: Pennsylvania
- Incorporation Country: United States
- Incorporation State/Province: Delaware
- Est. Current Fiscal Quarter End: March 31, 2015
- Est. Current Fiscal Year End: December 31, 2015
- Last Fiscal Quarter End: September 30, 2014
- Last Fiscal Year End: December 31, 2013
- Next Earnings Release: N/A
- NAICS: Biological Product (Except Diagnostic) Manufacturing
- NAICS Code: 325414
- NAICS Industry: Pharmaceutical and Medicine Manufacturing
- NAICS Sector: Manufacturing
Hemispherx Biopharma, Inc. is a specialty pharmaceutical company. It is engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
HEB Excel Add-In Codes
- Name: =YCI("HEB","name")
- Description: =YCI("HEB","description")
- Sector: =YCI("HEB","sector")
- Industry: =YCI("HEB","industry")
- Est. Current Fiscal Year End: =YCI("HEB","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.